메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한안과학회 Korean Journal of Ophthalmology Korean Journal of Ophthalmology 제28권 제1호
발행연도
2014.1
수록면
32 - 38 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: This study compared serum vascular endothelial growth factor (VEGF) concentration between patientsgiven the bilateral and unilateral intravitreal injections of bevacizumab. Methods: In a prospective manner, serum VEGF levels in treatment-naive patients with age-related macular degenerationwho underwent bilateral or unilateral intravitreal injections of bevacizumab were investigated. Afterinformed consent, peripheral blood was collected from in patients who underwent bilateral or unilateral intravitrealinjection of bevacizumab before and 1 month after the injection. Serum VEGF levels were measured byenzyme-linked immunosorbent assay after centrifugation. In addition, best-corrected visual acuity (BCVA) andcentral retinal thickness (CRT) before and 1 month after the injection were compared between each group. Results: Twenty patients received bilateral injections (40 eyes) and 20 patients received unilateral injections. The VEGF concentrations (pg/mL) before the bilateral injection were 235.75 ± 183.16 and 252.53 ± 233.52 forthe unilateral injection. They were significantly reduced to 153.88 ± 113.26 and 189.42 ± 251.72 after 1 month,respectively (p = 0.037 and 0.019), which are showing no significant difference between the two groups (p =0.771). And there were no significant intergroup difference in pre- and postoperative BCVA and CRT. Conclusions: The bilateral simultaneous intravitreal injection of bevacizumab did not differ greatly from unilateralintravitreal injection in the influence on serum VEGF levels and the therapeutic outcome.

목차

등록된 정보가 없습니다.

참고문헌 (23)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0